Biohaven Reports Positive Data From EEG Biomarker Study Of BHV-7000

(RTTNews) – Clinical-stage biopharmaceutical company Biohaven Ltd. (BHVN) Tuesday announced positive biomarker data from the Phase 1 electroencephalogram (EEG) biomarker study of its lead asset BHV-7000, proposed for the treatment of epilepsy. Examination of EEG in healthy subjects administered single … Continued

Michael Weisz appointed Yieldstreet CEO

Jul. 11, 2023, 07:00 AM Co-Founder Milind Mehere to transition to senior advisor and continue on Board of Directors Leadership Transition Comes as Yieldstreet Enters Next Phase of Growth NEW YORK, July 11, 2023 /PRNewswire/ — Yieldstreet (the “Company”), the … Continued

BiOWiSH Technologies and SABIC Agri-Nutrients Company Announce Bio-Enhanced Mineral Fertilizer Collaboration

July 21, 2022 10:00 AM Eastern Daylight Time CINCINNATI–(BUSINESS WIRE)–BiOWiSH Technologies, Inc. and SABIC Agri-Nutrients Company (SABIC AN) announced the successful completion of a year-long technical evaluation of BiOWiSH® Crop Liquid technology coated on SABIC’s urea in nine countries across five continents … Continued

Knopp Biosciences and Population Health Partners Create Areteia Therapeutics, New Clinical-Stage Asthma Company, with $350 Million in Funding

PITTSBURGH, Pa. & SHORT HILLS, N.J.–(BUSINESS WIRE)–Jul 12, 2022– Areteia Therapeutics, Inc. (“Areteia”) today announces its launch as a clinical-stage biopharmaceutical company focused on putting asthma patients in better control of their disease – and back in control of their … Continued